AIBS joined the American Society for Microbiology and 26 other scientific organizations in sending a letter to House and Senate appropriators urging robust funding for the Advanced Molecular Detection (AMD) program at the Centers for Disease Control and Prevention (CDC).
The letter calls for $175 million for the CDC AMD program in the fiscal year (FY) 2025 Labor, Health and Human Services, Education and Related Agencies bill. This funding level aligns with the level authorized in the Tracking Pathogens Act, which was enacted as part of a year-end legislative package in 2022.
“As we move beyond the COVID-19 pandemic, the AMD program continues to form new partnerships and to innovate so that cutting edge genomic and bioinformatic technologies can be deployed on the front lines of public health throughout the country and across the globe,” the groups note. “By bringing precision medicine to public health, the program gives the nation new tools to detect disease more quickly and more accurately, identify outbreaks sooner and protect people from emerging and evolving disease threats, whether seasonal such as influenza or RSV, endemic such as Lyme disease, or epidemic in nature.”
Stay current on the latest science policy news. Subscribe to our bi-weekly AIBS Public Policy Report.